CHICAGO, IL USA (UroToday.com) - Presented by Howard I. Scher,1 Karim Fizazi,2 Shih Yuan Lee,3 David B. MacLean,3 Iain J. Webb,4 Niels Borgstein,3 and Robert Dreicer5 at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting - May 30 - June 3, 2014 - Chicago, Illinois USA
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
1Memorial Sloan Kettering Cancer Center, New York, NY USA
2Institut Gustave Roussy, University of Paris Sud, Villejuif, France
3Takeda Pharmaceuticals International Co., Cambridge, MA USA
4Millennium: The Takeda Oncology Company, Cambridge, MA USA
5Cleveland Clinic, Cleveland, OH USA